Chronic Pain

SAN DIEGO — Finding ways to improve the patient experience, as well as increasing access to the appropriate health care providers, are key to addressing barriers to pain management, according to a speaker.

NEW ORLEANS — Evidence suggests that, for many patients, the harms of cannabis outweigh its potential benefits for chronic noncancer pain, according to new Best Practice Advice from ACP.

About 40% of patients in primary care have pain or illness that cannot be explained by diagnostic tests.

In response to the insightful cover story, “‘A potent medicine’: In matters of pain and trust, empathy may make all the difference,” published in the Healio Rheumatology January 2025 issue, I would like to highlight the key data on empathy.

Patients with kidney disease may be using cannabis recreationally or to treat symptoms without the knowledge of their health care team, according to results of a small survey of patients from a hemodialysis clinic in Canada.

Chronic chemotherapy-induced peripheral neuropathy is a substantial burden among people with cancer treated with chemotherapy, according to results of a systematic review and meta-analysis published in Regional Anesthesia & Pain Medicine.

Patients who experience musculoskeletal pain have many pharmaceutical options for relief — unless they also suffer from allergies to these medications.

American Society of Hematology has issued new sickle cell disease research priorities, highlighting seven key focus areas for maximum impact and benefit to patients.

SAN DIEGO — Pain coping skills training may be beneficial for pain interference and related outcomes for patients on hemodialysis, according to data presented at ASN Kidney Week.

SAN DIEGO — Kidney transplant recipients who experience more bodily pain have less involvement and ability to participate in social activities than kidney transplant patients who report less pain, according to data at ASN Kidney Week.